Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000084.xml
Synthesis 2004(4): 543-548
DOI: 10.1055/s-2004-815975
DOI: 10.1055/s-2004-815975
PAPER
© Georg Thieme Verlag Stuttgart · New York
A Short and Convenient Synthesis of New 1,2-Disubstituted Carbocyclic Nucleoside Analogues of Pyrimidine Based on a Cyclopentene Ring
Further Information
Received
23 October 2003
Publication Date:
12 February 2004 (online)
Publication History
Publication Date:
12 February 2004 (online)
Abstract
The synthesis of a new series of 1,2-disubstituted carbonucleoside analogues, pyrimidines of general structure I, is reported. These compounds were prepared in good yield from (±)-6-azabicyclo[3.2.0]hept-3-en-7-one (1) via two synthetic routes that involve NaBH4-mediated C-N bond cleavage as the key step. The uracil derivative Ia was halogenated with Cl, Br, and I at position 5 by treatment with the corresponding N-halosuccinimide.
Key words
nucleosides - reductions - amino alcohols - carbocycles - heterocycles
- 1
Chu CK.Baker DC. Nucleosides and Nucleotides as Antitumor and Antiviral Agents Plenum Press; New York: 1993. - 2
Cheson DK.Keating MJ.Plunkett W. Nucleoside Analogs in Cancer Therapy Marcel Dekker; New York: 1997. - 3
Mansour TS.Storer R. Curr. Pharm. Design 1997, 3: 227 - 4
Ichikawa E.Kato K. Curr. Med. Chem. 2001, 8: 385 - 5
Agrofoglio LA.Challand SR. Acyclic, Carbocyclic and l-Nucleosides Klumer Academic Publishers; Dordrecht: 1998. - 6
Simons C. Nucleoside Mimetics their Chemistry and Biological Properties Gordon and Breach Science Publishers; Amsterdam: 2001. - 7
Marquez VE. Adv. Antiviral Drug Des. 1996, 2: 89 - 8
Zhu X.-F. Nucleosides, Nucleotides Nucleic Acids 2000, 19: 651 - 9
De Clercq E. Nat. Rev. Drug Discovery 2002, 1: 13 - 10
Estrada E.Uriarte E.Montero A.Teijeira M.Santana L.De Clercq E. J. Med. Chem. 2000, 43: 1975 - 11
Santana L.Teijeira M.Terán C.Uriarte E.Viña D. Synthesis 2001, 1532 - 12
Besada P.González-Moa MJ.Terán C.Santana L.Uriarte E. Synthesis 2002, 2445 -
13a
Bridges GS.Ahmed SP.Sunkara PS.McCarty JR.Tyms AS. Antivir. Res. 1995, 27: 325 -
13b
Foye WO. Cancer Chemotherapeutic Agents American Chemical Society; Washington: 1995. -
14a
Farina V.Hauck SI. Synlett 1991, 157 -
14b
Robins MJ.Barr PJ. J. Org. Chem. 1983, 48: 1854 -
14c
Tsvetkov AV.Latyshev GV.Lukashev NV.Beletskaya IP. Tetrahedron Lett. 2002, 43: 7267 - 15
Sheally YF.O’Dell CA. J. Heterocycl. Chem. 1976, 13: 1041 - 16
Hronowski LJ.Szarek WA. Can. J. Chem. 1985, 63: 2787 - 17
Santana L.Teijeira M.Uriarte E. J. Heterocycl. Chem. 1999, 36: 1 -
18a
Tietze LF.Schemeider C.Pretor M. Synthesis 1993, 1079 -
18b
Fernández F.García-Mera X.Morales M.Rodríguez-Borges JE. Synthesis 2001, 239 - 19
Katagiri N.Muto M.Nomura M.Higashikawa T.Kaneko C. Chem. Pharm. Bull. 1991, 39: 1112 - 20
Katagiri N.Nomura M.Sato H.Kaneko C.Yusa K.Tsuruo T. J. Med. Chem. 1992, 35: 1882 - 21
Awano H.Shuto S.Baba M.Kira T.Shigeta S.Matsuda A. Bioorg. Med. Chem. Lett. 1994, 4: 367